The DOI matches its Crossref record; 251 of the 257 references it cites were found in a registry or an index.
Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: To update practice guidelines for the therapeutic use of androgens in women. PARTICIPANTS: A Task Force appointed by the Endocrine Society, American Congress of Obestricians and Gynecologists (ACOG), American Society for Reproductive Medicine (ASRM), European Society of Endocrinology (ESE), and International Menopause Society (IMS) consisting of six experts, a methodologist, and a medical writer. EVIDENCE: The Task Force commissioned two systematic reviews of published data and considered several other existing meta-analyses and trials. The GRADE methodology was used; the strength of a recommendation is indicated by a number "1" (strong recommendation, we recommend) or "2" (weak recommendation, we suggest). CONSENSUS PROCESS: Multiple e-mail communications and conference calls determined consensus. Committees of the Endocrine Society, ASRM, ACOG, ESE, and IMS reviewed and commented on the drafts of the guidelines. CONCLUSIONS: We continue to recommend against making a diagnosis of androgen deficiency syndrome in healthy women because there is a lack of a well-defined syndrome, and data correlating androgen levels with specific signs or symptoms are unavailable. We recommend against the general use of T for the following indications: infertility; sexual dysfunction other than hypoactive sexual desire disorder; cognitive, cardiovascular, metabolic, or bone health; or general well-being. We recommend against the routine use of dehydroepiandrosterone due to limited data concerning its effectiveness and safety in normal women or those with adrenal insufficiency. We recommend against the routine prescription of T or dehydroepiandrosterone for the treatment of women with low androgen levels due to hypopituitarism, adrenal insufficiency, surgical menopause, pharmacological glucocorticoid administration, or other conditions associated with low androgen levels because there are limited data supporting improvement in signs and symptoms with therapy and no long-term studies of risk. Evidence supports the short-term efficacy and safety of high physiological doses of T treatment of postmenopausal women with sexual dysfunction due to hypoactive sexual desire disorder. Importantly, endogenous T levels did not predict response to therapy. At present, physiological T preparations for use in women are not available in many countries including the United States, and long-term safety data are lacking. We recommend that any woman receiving T therapy be monitored for signs and symptoms of androgen excess. We outline areas for future research. Ongoing improvement in androgen assays will allow a redefinition of normal ranges across the lifespan; this may help to clarify the impact of varying concentrations of plasma androgens on the biology, physiology, and psychology in women and lead to indications for therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.8.606 · Cited by 1,799
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Atkins, D., Eccles, M., Flottorp, S., Guyatt, G. H., Henry, D., Hill, S., Liberati, A., O'Connell, D., Oxman, A. D., Phillips, B., et al. (2004) · BMC Health Services Research · doi:10.1186/1472-6963-4-38 · Cited by 1,235
ANDERSON, D. C. (1974) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1974.tb03298.x · Cited by 1,127
Södergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080
Research works printed but not linked: 6
- [13]13. Braunstein GD, Reitz RE, Buch A, Schnell D, Caulfield MP. Tes- tosterone reference ranges in normally cycling healthy premeno- pausal women. J Sex Med. 2011;8:2924 -2934.
- [28]28. Ly LP, Sartorius G, Hull L, et al. Accuracy of calculated free tes- tosterone formulae in men. Clin Endocrinol (Oxf). 2010;73:382- 388.
- [31]31. Rosner W. An extraordinarily inaccurate assay for free testoster- one is still with us. J Clin Endocrinol Metab. 2001;86:2903.
- [179]179. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hyster- ectomy and sexual functioning. JAMA. 1999;282:1934 -1941.
- [182]182. Snabes MC, Zborowski J, Simes S. Libigel (testosterone gel) does not differentiate from placebo therapy in the treatment of hypo- active sexual desire in postmenopausal women. J Sex Med. 2012; 3:171.
- [195]195. Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer. 1997;79:494 -499.
Cited by
Sorted by citations
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R., Panay, N., & Fenton, A. J. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 968
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Self-citationThe Menopause Transition: Signs, Symptoms, and Management Options
Santoro, N. F., Roeca, C. M., Peters, B. A., & Neal-Perry, G. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa764 · Cited by 774
Self-citationLong-term health consequences of premature or early menopause and considerations for management
Faubion, S. S., Kuhle, C. L., Shuster, L. T., & Rocca, W. A. (2015) · Climacteric · doi:10.3109/13697137.2015.1020484 · Cited by 566
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
Sullivan, S. D., Sarrel, P. M., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.046 · Cited by 519
Davis, S. R., Lambrinoudaki, I. V., Lumsden, M.-A., Mishra, G. D., Pal, L., REES, M. C. P., Santoro, N. F., & Simoncini, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.4 · Cited by 506
Self-citationHusebye, E. S., Pearce, S. H., Krone, N. P., & Kämpe, O. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00136-7 · Cited by 378
Testosterone in women—the clinical significance
Davis, S. R., & Wåhlin-Jacobsen, S. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00284-3 · Cited by 311
Self-citationTestosterone therapy for transgender men
Irwig, M. S. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00036-x · Cited by 272
Clayton, A. H., Goldstein, I., Kim, N. N., Althof, S. E., Faubion, S. S., Faught, B. M., Parish, S. J., Simon, J. A., Vignozzi, L., Christiansen, K., et al. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.11.002 · Cited by 226
Self-citationImpact of estrogens in males and androgens in females
Hammes, S. R., & Levin, E. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125755 · Cited by 252
Nieschlag, E., & Vorona, E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0080 · Cited by 237
Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment
Parish, S. J., & Hahn, S. R. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2015.11.009 · Cited by 236
Revised Global Consensus Statement on Menopausal Hormone Therapy
de Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., REES, M. C. P., Yang, C., & Pierroz, D. D. (2016) · Climacteric · doi:10.1080/13697137.2016.1196047 · Cited by 198
Scavello, I., Maseroli, E., Stasi, V. D., & Vignozzi, L. (2019) · Medicina · doi:10.3390/medicina55090559 · Cited by 187
Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment
Flores, V. A., Pal, L., & Manson, J. E. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab011 · Cited by 174
(2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003324 · Cited by 174
Parish, S. J., Simon, J. A., Davis, S. R., Giraldi, A. G. E., Goldstein, I., Goldstein, S. W., Kim, N. N., Kingsberg, S. A., Morgentaler, A., Nappi, R. E., et al. (2021) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.10.009 · Cited by 164
Self-citationMenopause hormone therapy: latest developments and clinical practice
Fait, T. (2018) · Drugs in Context · doi:10.7573/dic.212551 · Cited by 148
Recent advances in the understanding and management of polycystic ovary syndrome
Rocha, A. L., Oliveira, F. R., Azevedo, R. C., Silva, V. A., Peres, T. M., Candido, A. L., Gomes, K. B., & Reis, F. M. (2019) · F1000Research · doi:10.12688/f1000research.15318.1 · Cited by 142
Sexual Dysfunction in Women: A Practical Approach.
Faubion, S. S., & Rullo, J. (2015) · PubMed · Cited by 135
Clinical Effects of Early or Surgical Menopause
Kingsberg, S. A., Larkin, L. C., & LIU, J. H. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003729 · Cited by 160
The 2020 Menopausal Hormone Therapy Guidelines
Lee, S. R., Cho, M. K., Cho, Y. J., Chun, S., Hong, S.-H., Hwang, K. R., Jeon, G., Joo, J. K., Kim, S. K., Lee, D. O., et al. (2020) · Journal of Menopausal Medicine · doi:10.6118/jmm.20000 · Cited by 136
Sexual well-being after menopause: An International Menopause Society White Paper
Simon, J. A., Davis, S. R., Althof, S. E., Chedraui, P. A., Clayton, A. H., Kingsberg, S. A., Nappi, R. E., Parish, S. J., & Wolfman, W. (2018) · Climacteric · doi:10.1080/13697137.2018.1482647 · Cited by 133
Self-citationDavis, S. R., Worsley, R., Miller, K. K., Parish, S. J., & Santoro, N. F. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.033 · Cited by 125
Self-citationHormone replacement therapy in young women with surgical primary ovarian insufficiency
Sarrel, P. M., Sullivan, S. D., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.018 · Cited by 129
Female Sexual Dysfunction—Medical and Psychological Treatments, Committee 14
Kingsberg, S. A., Althof, S. E., Simon, J. A., Bradford, A. M., Bitzer, J., Carvalho, J., Flynn, K. E., Nappi, R. E., Reese, J. B., Rezaee, R. L., et al. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.05.018 · Cited by 132
Fluorine in the Pharmaceutical Industry: FDA‐Approved Fluorine‐Containing Drugs in 2024
Du, Y., Bian, Y., Baecker, D., Dhawan, G., Semghouli, A., Kiss, L., Zhang, W., Sorochinsky, A. E., Soloshonok, V. A., & Han, J. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202500662 · Cited by 120
Fleseriu, M., Christ‐Crain, M., Langlois, F., Gadelha, M. R., & Melmed, S. K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00342-8 · Cited by 127
11-oxygenated C19 steroids Do not decline with age in women
Nanba, A. T., Rege, J., Ren, J., Auchus, R. J., Rainey, W. E., & Turcu, A. F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02527 · Cited by 113
EMAS position statement: The ten point guide to the integral management of menopausal health
Neves-e-Castro, M., Birkhäuser, M., Samsioe, G., Lambrinoudaki, I. V., Palacios, S., Sánchez‐Borrego, R., Llaneza, P., Ceauşu, I., Depypere, H. T., Erel, C. T., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.02.003 · Cited by 110
An Update on Addison’s Disease
Barthel, A., Benker, G., Berens, K., Diederich, S., Manfras, B. J., Grüber, M., Kanczkowski, W., Kline, G. A., Kamvissi, V., Hahner, S., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0804-2715 · Cited by 115
Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause
Kagan, R., Kellogg‐Spadt, S., & Parish, S. J. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00700-w · Cited by 103
Hormones and Aging: An Endocrine Society Scientific Statement
Cappola, A. R., Auchus, R. J., Fuleihan, G. E., Handelsman, D. J., Kalyani, R. R., McClung, M. R., Stuenkel, C. A., Thorner, M. O., & Verbalis, J. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad225 · Cited by 108
Labrie, F., Derogatis, L. R., Archer, D. F., Koltun, W. D., Vachon, A., Young, D. G., Frenette, L., Portman, D. J., Montesino, M., Côté, I., et al. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.13045 · Cited by 94
Premature ovarian insufficiency: A toolkit for the primary care physician
Lambrinoudaki, I. V., Paschou, S. Α., Lumsden, M. A., Faubion, S. S., Makrakis, E., Kalantaridou, S., & Panay, N. (2021) · Maturitas · doi:10.1016/j.maturitas.2020.11.004 · Cited by 80
Vegunta, S., Kling, J. M., & Kapoor, E. (2019) · Journal of Women s Health · doi:10.1089/jwh.2018.7494 · Cited by 96
Advances in pharmacotherapy for treating female sexual dysfunction
Nappi, R. E., & Cucinella, L. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1020791 · Cited by 76
Santoro, N. F., Braunstein, G. D., Butts, C. L., Martin, K. A., McDermott, M., & Pinkerton, J. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1271 · Cited by 75
Self-citationImpact of Contraception on Female Sexual Function
Casey, P. M., MacLaughlin, K. L., & Faubion, S. S. (2016) · Journal of Women s Health · doi:10.1089/jwh.2015.5703 · Cited by 74
Androgen Therapy in Neurodegenerative Diseases
Bianchi, V. E., Rizzi, L., Bresciani, E., Omeljaniuk, R. J., & Torsello, A. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa120 · Cited by 69
Soman, M., Huang, L.-C., Cai, W.-H., Xu, J.-B., Chen, J.-Y., He, R.-K., Ruan, H.-C., Xu, X.-R., Qian, Z.-D., & Zhu, X.-M. (2019) · Menopause · doi:10.1097/gme.0000000000001161 · Cited by 63
Alexandraki, K., & Grossman, A. B. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122153 · Cited by 64
Premature ovarian insufficiency
McGlacken-Byrne, S. M., & Conway, G. S. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2021.09.011 · Cited by 58
Fagman, J. B., Wilhelmson, A. S., Motta, B. M., Pirazzi, C., Alexanderson, C., Gendt, K. D., Verhoeven, G., Holmäng, A. B., Anesten, F., Jansson, J., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-259234 · Cited by 55
A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada
Krakowsky, Y., & Grober, E. D. (2018) · Canadian Urological Association Journal · doi:10.5489/cuaj.4907 · Cited by 56
Testosterone Therapy: Review of Clinical Applications.
Petering, R. C., & Brooks, N. A. (2017) · PubMed · Cited by 51
Parish, S. J., Simon, J. A., Davis, S. R., Giraldi, A. G. E., Goldstein, I., Goldstein, S. W., Kim, N. N., Kingsberg, S. A., Morgentaler, A., Nappi, R. E., et al. (2021) · Journal of Women s Health · doi:10.1089/jwh.2021.29037 · Cited by 52
Self-citationWomen's Sexual Health and Aging
Granville, L. J., & Pregler, J. P. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15198 · Cited by 55
Androgens and Psychosocial Factors Related to Sexual Dysfunctions in Premenopausal Women∗
Wåhlin-Jacobsen, S., Kristensen, E., Pedersen, A. T., Læssøe, N. C., Cohen, A. S., HOUGAARD, D. M., Lundqvist, M., & Giraldi, A. G. E. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.12.237 · Cited by 49
White, H. D., Brown, L., Gyurik, R. J., Manganiello, P. D., Robinson, T. D., Hallock, L. S., Lewis, L. D., & Yeo, K.-T. J. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.05.016 · Cited by 48
Jayasena, C. N., Alkaabi, F., Liebers, C. S., Handley, T. J., Franks, S., & Dhillo, W. S. (2018) · Clinical Endocrinology · doi:10.1111/cen.13906 · Cited by 51
Wang, J., Fan, X., Yang, M., Song, M., Wang, K., Giovannucci, E. L., Ma, H., Jin, G., Hu, Z., Shen, H., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1253 · Cited by 46
Howard, L. M., Wilson, C. A., Reilly, T. J., Moss, K. M., Mishra, G. D., Coupland‐Smith, E., Riecher‐Rössler, A., Seedat, S., Smith, S. M., Steinberg, J. R., et al. (2025) · World Psychiatry · doi:10.1002/wps.21305 · Cited by 60
The Association of Serum Testosterone Levels and Urinary Incontinence in Women
Kim, M. M., & Kreydin, E. I. (2017) · The Journal of Urology · doi:10.1016/j.juro.2017.08.093 · Cited by 45
Changes of androgens levels in menopausal women
Brzozowska, M., & Lewiñski, A. (2020) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2020.101941 · Cited by 45
Are Endogenous Androgens Linked to Female Sexual Function? A Systemic Review and Meta-Analysis
Maseroli, E., & Vignozzi, L. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2022.01.515 · Cited by 44
Brubaker, L. W., & Guntupalli, S. R. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003941 · Cited by 52
Gray, P. B., Straftis, A. A., Bird, B. M., McHale, T. S., & Zilioli, S. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.04.017 · Cited by 45
Androgens in postmenopausal women: a review
Shifren, J. L., & Davis, S. R. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000903 · Cited by 42
Self-citationSexual Function Post-Breast Cancer
Streicher, L. F., & Simon, J. A. (2018) · Cancer treatment and research · doi:10.1007/978-3-319-70197-4_11 · Cited by 40
Uloko, M., Rahman, F., Puri, L. I., & Rubin, R. S. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-022-00613-0 · Cited by 48
A model of care for healthy menopause and ageing: EMAS position statement
Stute, P., Ceauşu, I., Depypere, H. T., Lambrinoudaki, I. V., Mueck, A. O., Pérez-López, F. R., van der Schouw, Y. T., Senturk, L. M., Simoncini, T., Stevenson, J. C., et al. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.06.018 · Cited by 38
Androgens and cardiovascular disease in women and men
Armeni, E., & Lambrinoudaki, I. V. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.07.010 · Cited by 39
Viuff, M. H., Just, J., Brun, S., Dam, T. V., Hansen, M., Melgaard, L., Hougaard, D. M., Lappe, M., & Gravholt, C. H. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac167 · Cited by 35
An Update on Advances in Hypopituitarism: Etiology, Diagnosis, and Current Management
Iglesias, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206161 · Cited by 40
McClements, L., Kautzky‐Willer, A., Kararigas, G., Ahmed, S. B., & Stallone, J. N. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00714-7 · Cited by 42
Intrinsic links among sex, emotion, and reproduction
Yang, L. Y., Comninos, A. N., & Dhillo, W. S. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2802-3 · Cited by 37
Sport, doping and female fertility
Vignera, S. L., Condorelli, R. A., Cannarella, R., Duca, Y., & Calogero, A. E. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0437-8 · Cited by 39
MANAGEMENT OF ENDOCRINE DISEASE: Female sexual dysfunction for the endocrinologist
Carosa, E., Sansone, A., & Jannini, E. A. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0903 · Cited by 35
Kingsberg, S. A., & Simon, J. A. (2020) · Journal of Women s Health · doi:10.1089/jwh.2019.7865 · Cited by 38
Postmenopausal Hyperandrogenism
Zaman, A., & Rothman, M. S. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.12.002 · Cited by 33
A Model for the Management of Female Sexual Dysfunctions
Scalco, S. C. P., Troncon, J. K., Lopes, G. P., & Lara, L. A. D. S. (2017) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0037-1601435 · Cited by 32
Should Dehydroepiandrosterone Be Administered to Women?
Wierman, M. E., & Kiseljak‐Vassiliades, K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac130 · Cited by 31
Self-citationManaging premature menopause and sexual dysfunction
Zhou, E. S., Falk, S. J., & Bober, S. L. (2015) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000156 · Cited by 30
An integrated single-cell analysis of human adrenal cortex development
del Valle, I., Young, M. D., Kildisiute, G., Ogunbiyi, O. K., Buonocore, F., Simcock, I. C., Khabirova, E., Crespo, B., Moreno, N., Brooks, T., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.168177 · Cited by 31
Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction
Cipriani, S., Maseroli, E., Stasi, V. D., Scavello, I., Todisco, T., Rastrelli, G., Fambrini, M., Sorbi, F., Petraglia, F., Jannini, E. A., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01598-1 · Cited by 30
Weiss, R. V., Hohl, A., Athayde, A. L., Pardini, D., Gomes, L. G., de Oliveira, M., Meirelles, R. M. R., Clapauch, R., & Spritzer, P. M. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000152 · Cited by 28
SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALS
Linares, G. R., Li, Y., Chang, W.-H., Rubin-Sigler, J., Mendonca, S., Hong, S., Eoh, Y., Guo, W., Huang, Y., Chang, J., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.01.005 · Cited by 28
To be or not to be in sexual desire: the androgen dilemma
Nappi, R. E. (2015) · Climacteric · doi:10.3109/13697137.2015.1064268 · Cited by 28
Disfunción sexual femenina: opciones de tratamiento farmacológico
Montero, A. A., & Carnerero, C. I. S. (2016) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2016.02.008 · Cited by 30
Dasinger, J. H., Intapad, S., Rudsenske, B., Davis, G. K., Newsome, A. D., & Alexander, B. T. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07548 · Cited by 26
Kumar, S., Mukherjee, S., O’Dwyer, C., Wassersug, R. J., Bertin, E., Mehra, N., Dahl, M., Genoway, K. A., & Kavanagh, A. G. (2022) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2022.03.003 · Cited by 25
Tucker, P. E., & Cohen, P. A. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000943 · Cited by 24
Prescribing testosterone and DHEA: The role of androgens in women
Smith, T. L., & Batur, P. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20030 · Cited by 25
Nouri, N., Maleki, L. A., & Yousefi, M. (2021) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2021.103363 · Cited by 25
Effects of testosterone therapy for women: a systematic review and meta-analysis protocol
Islam, R. M., Bell, R. J., Green, S., & Davis, S. R. (2019) · Systematic Reviews · doi:10.1186/s13643-019-0941-8 · Cited by 25
Self-citationOspina, N. S., Rodríguez‐Gutiérrez, R., Brito, J. P., Young, W. F., & Montori, V. M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0435-z · Cited by 25
Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk
Singh, P., Covassin, N., Marlatt, K. L., Gadde, K. M., & Heymsfield, S. B. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210014 · Cited by 43
Garmes, H. M., Boguszewski, C. L., Miranda, P. A. C., Martins, M. R. A., Correa‐Silva, S. R., Abucham, J., Musolino, N. R. D. C., Vilar, L., Portari, L. H. C., Gadelha, M. R., et al. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000335 · Cited by 23
Androgen-based therapies in women
Whitton, K., & Baber, R. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101783 · Cited by 24
Sakhteman, A., Pasdaran, A., Afifi, M., & Hamedi, A. (2020) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x20932527 · Cited by 22
Krapf, J. M., & Simon, J. A. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000863 · Cited by 23
Pulzer, A., Burger‐Stritt, S., & Hahner, S. (2016) · Der Internist · doi:10.1007/s00108-016-0054-6 · Cited by 24
Cardiovascular and metabolic actions of the androgens: Is testosterone a Janus-faced molecule?
Stallone, J. N., & Oloyo, A. K. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115347 · Cited by 22
Autoimmune primary adrenal insufficiency -current diagnostic approaches and future perspectives
Wolff, A. S. B., Kucuka, I., & Oftedal, B. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1285901 · Cited by 28
Dihydrotestosterone induces arterial stiffening in female mice
Horton, A. C., Wilkinson, M. M., Kilanowski‐Doroh, I., Dong, Z., Liu, J., Ogola, B. O., Visniauskas, B., & Lindsey, S. H. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00586-3 · Cited by 21
Testosterone in Women: Measurement and Therapeutic Use
Korkidakis, A., & Reid, R. L. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.01.006 · Cited by 21
A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency
Charoensri, S., & Auchus, R. J. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1894 · Cited by 22
Distressing Sexual Function at Midlife
Simon, J. A., & Lukas, V. A. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002268 · Cited by 20
Metadata
- Authors
- Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N.
- Affiliations
- University of British Columbia (CA)
- University of Birmingham (GB)
- Veterans Health Administration (US)
- Massachusetts General Hospital (US)
- Mayo Clinic (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-10
- Volume
- 99
- Issue
- 10
- Pages
- 3489-3510
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2169638329
- Semantic Scholar
- 0ab9fec7488d4092d18727dbe6ea5d548da84c6e
- Cited by
- 363
- References
- 257
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 27 · 2023: 22 · 2022: 52 · 2021: 46 · 2020: 28 · 2019: 25 · 2018: 31 · 2017: 27 · 2016: 34 · 2015: 25 · 2014: 3
- FWCI
- 23.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- androgen therapy, women, testosterone, dehydroepiandrosterone, hypoactive sexual desire disorder, postmenopausal women, adrenal insufficiency, hypopituitarism, surgical menopause, hyperandrogenism, infertility, sexual dysfunction, bone health, cardiovascular risk, treatment safety
- MeSH terms
- Contraindications, Androgens, Endocrinology, Female, Humans, Hypopituitarism, Societies, Medical, Practice Guidelines as Topic, Evidence-Based Medicine, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
